Common Variable Immunodeficiency Patient Fecal Microbiota Transplant Recapitulates Gut Dysbiosis

Purpose Patients with non-infectious complications have worse clinical outcomes in common variable immunodeficiency (CVID) than those with infections-only. Non-infectious complications are associated with gut microbiome aberrations, but there are no reductionist animal models that emulate CVID. Our aim in this study was to uncover potential microbiome roles in the development of non-infectious complications in CVID. Methods We examined fecal whole genome shotgun sequencing from patients CVID, and non-infectious complications, infections-only, and their household controls. We also performed Fecal Microbiota transplant from CVID patients to Germ-Free Mice. Results We found potentially pathogenic microbes Streptococcus parasanguinis and Erysipelatoclostridium ramosum were enriched in gut microbiomes of CVID patients with non-infectious complications. In contrast, Fusicatenibacter saccharivorans and Anaerostipes hadrus, known to suppress inflammation and promote healthy metabolism, were enriched in gut microbiomes of infections-only CVID patients. Fecal microbiota transplant from non-infectious complications, infections-only, and their household controls into germ-free mice revealed gut dysbiosis patterns in recipients from CVID patients with non-infectious complications, but not infections-only CVID, or household controls recipients. Conclusion Our findings provide a proof of concept that fecal microbiota transplant from CVID patients with non-infectious complications to Germ-Free mice recapitulates microbiome alterations observed in the donors.

[1]  C. Alauzet,et al.  In Silico Study of Cell Surface Structures of Parabacteroides distasonis Involved in Its Maintenance within the Gut Microbiota , 2022, International journal of molecular sciences.

[2]  L. Beney,et al.  Description of a Newly Isolated Blautia faecis Strain and Its Benefit in Mouse Models of Post-Influenza Secondary Enteric and Pulmonary Infections , 2022, Nutrients.

[3]  Fatemeh Almodaresi,et al.  AGAMEMNON: an Accurate metaGenomics And MEtatranscriptoMics quaNtificatiON analysis suite , 2022, Genome biology.

[4]  Fatih Çölkesen,et al.  Evaluation of malnutrition risk and nutrition status in adult patients with common variable immunodeficiency. , 2022, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[5]  C. Cunningham-Rundles,et al.  Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency , 2021, JCI insight.

[6]  M. Jarvelin,et al.  Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies , 2021, Diabetologia.

[7]  J. Litzman,et al.  Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates , 2021, Frontiers in Immunology.

[8]  S. Janković,et al.  Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review , 2021, Revista do Instituto de Medicina Tropical de Sao Paulo.

[9]  F. Velluzzi,et al.  Gut microbiota markers associated with obesity and overweight in Italian adults , 2021, Scientific Reports.

[10]  T. N. Sviridova,et al.  Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia , 2021, Heliyon.

[11]  Huijue Jia,et al.  Gut microbiota perturbation in IgA deficiency is influenced by IgA-autoantibody status. , 2021, Gastroenterology.

[12]  K. Bonham,et al.  Comparative Analysis of 16S rRNA Gene and Metagenome Sequencing in Pediatric Gut Microbiomes , 2021, bioRxiv.

[13]  R. Knight,et al.  Challenges in benchmarking metagenomic profilers , 2020, Nature Methods.

[14]  H. Völzke,et al.  Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function , 2020, Gut.

[15]  A. Bulashevska,et al.  Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea , 2020, Frontiers in Immunology.

[16]  N. D. Djadid,et al.  Measuring of IgG2c isotype instead of IgG2a in immunized C57BL/6 mice with Plasmodium vivax TRAP as a subunit vaccine candidate in order to correct interpretation of Th1 versus Th2 immune response. , 2020, Experimental parasitology.

[17]  R. Knight,et al.  Household paired design reduces variance and increases power in multi-city gut microbiome study in multiple sclerosis , 2020, Multiple sclerosis.

[18]  F. Magne,et al.  The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? , 2020, Nutrients.

[19]  L. McCullough,et al.  Gut Microbiota–Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice , 2020, Circulation research.

[20]  C. Cunningham-Rundles,et al.  Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis , 2020, Frontiers in Immunology.

[21]  F. Vaca-Paniagua,et al.  Gut microbiota in Mexican patients with common variable immunodeficiency. , 2020, Gaceta medica de Mexico.

[22]  Werner Müller,et al.  The Essential Role Played by B Cells in Supporting Protective Immunity Against Trichuris muris Infection Is by Controlling the Th1/Th2 Balance in the Mesenteric Lymph Nodes and Depends on Host Genetic Background , 2019, Front. Immunol..

[23]  J. Gilbert,et al.  Community ecology as a framework for human microbiome research , 2019, Nature Medicine.

[24]  J. Raes,et al.  The neuroactive potential of the human gut microbiota in quality of life and depression , 2019, Nature Microbiology.

[25]  Shuangjiang Liu,et al.  Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. , 2019, Cell reports.

[26]  A. Budding,et al.  Single Sampling Versus Multiple Testing Strategy to Assess Gut Microbiota Composition: Does It Matter? , 2019, Current Microbiology.

[27]  A. Morgun,et al.  CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont. , 2018, Clinical immunology.

[28]  K. Tanimoto,et al.  First case report of bacteremia caused by Dysgonomonas mossii. , 2018, Anaerobe.

[29]  N. Ajami,et al.  Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice , 2018, Antimicrobial Agents and Chemotherapy.

[30]  F. Brombacher,et al.  Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection , 2018, Scientific Reports.

[31]  J. Walter,et al.  Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets , 2018, Front. Immunol..

[32]  E. Le Chatelier,et al.  Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients , 2018, Science.

[33]  M. Yassour,et al.  A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients , 2017, Genome Medicine.

[34]  A. Travis,et al.  Human Gut Symbiont Roseburia hominis Promotes and Regulates Innate Immunity , 2017, Front. Immunol..

[35]  J. V. van Laar,et al.  Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences. , 2017, Trends in immunology.

[36]  P. Oppezzo,et al.  Noninfectious complications in patients with pediatric‐onset common variable immunodeficiency correlated with defects in somatic hypermutation but not in class‐switch recombination , 2017, The Journal of allergy and clinical immunology.

[37]  Shimin Zhao,et al.  Butyrate induces apoptosis by activating PDC and inhibiting complex I through SIRT3 inactivation , 2017, Signal Transduction and Targeted Therapy.

[38]  T. Kanai,et al.  A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients , 2016, Inflammatory Bowel Diseases.

[39]  Jiabao Li,et al.  Diet Diversity Is Associated with Beta but not Alpha Diversity of Pika Gut Microbiota , 2016, Front. Microbiol..

[40]  Liping Zhao,et al.  Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium , 2016, Scientific Reports.

[41]  W. Teughels,et al.  Antimicrobial effects of commensal oral species are regulated by environmental factors. , 2016, Journal of dentistry.

[42]  T. Karlsen,et al.  Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation , 2016, Mucosal Immunology.

[43]  Michael J. Barratt,et al.  Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children , 2016, Science.

[44]  J. Doré,et al.  Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery , 2015, Gut.

[45]  S. Spector,et al.  Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.

[46]  J. Kolls,et al.  Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia , 2015, Infection and Immunity.

[47]  Nayoung Kim,et al.  Metabolism of Kaempferia parviflora polymethoxyflavones by human intestinal bacterium Bautia sp. MRG-PMF1. , 2014, Journal of agricultural and food chemistry.

[48]  K. Warnatz,et al.  Immunodeficiency in adults a practical guide for the allergist , 2014, Allergo Journal International.

[49]  I. Quinti,et al.  Longitudinal Study on Health-Related Quality of Life in a Cohort of 96 Patients with Common Variable Immune Deficiencies , 2014, Front. Immunol..

[50]  E. Zoetendal,et al.  Human intestinal microbiota composition is associated with local and systemic inflammation in obesity , 2013, Obesity.

[51]  Se Jin Song,et al.  Cohabiting family members share microbiota with one another and with their dogs , 2013, eLife.

[52]  J. Stockman.  Morbidity and mortality in common variable immune deficiency over 4 decades , 2013 .

[53]  C. Cunningham-Rundles.  The many faces of common variable immunodeficiency. , 2012, Hematology. American Society of Hematology. Education Program.

[54]  D. Douek,et al.  Microbial translocation in HIV infection: causes, consequences and treatment opportunities , 2012, Nature Reviews Microbiology.

[55]  Dae-Wook Kang,et al.  Effects of gut microbes on nutrient absorption and energy regulation. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[56]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[57]  J. Park,et al.  A Case of Pneumonia and Parapneumonic Effusion Caused by Streptococcus parasanguinis , 2011 .

[58]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[59]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[60]  M. Kussmann,et al.  Influence of gut microbiota on mouse B2 B cell ontogeny and function. , 2011, Molecular immunology.

[61]  J. Ravetch,et al.  FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo , 2010, Proceedings of the National Academy of Sciences.

[62]  C. Doern,et al.  It's Not Easy Being Green: the Viridans Group Streptococci, with a Focus on Pediatric Clinical Manifestations , 2010, Journal of Clinical Microbiology.

[63]  C. Cunningham-Rundles,et al.  Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions , 2009, British journal of haematology.

[64]  C. Galambos.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes , 2009 .

[65]  B. Hoen,et al.  Characteristics and regional variations of group D streptococcal endocarditis in France. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[66]  K. Oana,et al.  First isolation of Dysgonomonas mossii from intestinal juice of a patient with pancreatic cancer. , 2006, Archives of medical research.

[67]  D. Raoult,et al.  Bacillus massiliensis sp. nov., isolated from cerebrospinal fluid. , 2006, International journal of systematic and evolutionary microbiology.

[68]  P. Bruhns,et al.  FcγRIV : A novel FcR with distinct IgG subclass specificity , 2005 .

[69]  Roland M. Martin,et al.  The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. , 1998, Journal of immunological methods.

[70]  G. D. Martich,et al.  Response of man to endotoxin. , 1993, Immunobiology.

[71]  Y. Fujiyama,et al.  Clostridium ramosum, an IgA Protease‐Producing Species and Its Ecology in the Human Intestinal Tract , 1985, Microbiology and immunology.